Denali Therapeutics
This role involves developing and validating analytical methods for large molecule therapeutics, focusing on product release, stability, and characterization testing. The position requires collaboration with bioprocess and formulation teams to support the development of therapies that cross the blood-brain barrier. The successful candidate will contribute to experimental design, data analysis, and documentation within a biotechnology setting.
Headquarters
South San Francisco, California, United States
Company Size
201-500 employees
Founded
2015
Denali Therapeutics brings the power of biotherapeutics to the whole body, including the brain. We discover, develop and deliver medicines for people living with serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Denali Therapeutics.
Associate / Principal Scientist - Analytical Development
Elanco
Scientist - Analytical Assay
Eurofins
Advisor, Analytical Separations & Biochemistry, Analytical Development - BR&D
Eli Lilly and Company
Entry Level Scientist
Pace® Analytical Services
Technician, Purification
Terray Therapeutics
Principal Scientist, Large Molecule Analytical
MSD